Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

Pharmaceutical social media after Cambridge Analytica

As MPs call for the regulation of social media companies, what are the ethical and compliance implications for the pharmaceutical industry?

- PMLiVE

Gene therapy market access Q&A

Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult gives his personal view on how to get the new therapies to patients

- PMLiVE

Bluebird: on a mission to ‘recode’ the DNA of healthcare

Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector

- PMLiVE

Brexit “having impact on EU drug development”

EMA and UK regulator both affected

- PMLiVE

Pfizer buys dwarfism drug company Therachon for $810m

Will rival BioMarin pipeline drug

- PMLiVE

Q&A with Tim Cockroft

PME interviews the founding director of akt health communications

- PMLiVE

Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers

Will also advance proteomics research

Cultivating a learner-led culture: agile learning and the growth mindset

In this month’s Smart Thinking blog on PM.Live.com, Michelle Sweet, Learning and Development Consultant at Lucid Group, discusses the needs for a learner-led culture and a growth mindset in the...

Lucid Group Communications Limited

- PMLiVE

Akcea gets first OK for Waylivra in rare triglyceride disorder

EU becomes the first market for the new drug

- PMLiVE

AZ’s bet on Daiichi’s rival to Kadcyla pays off

Pivotal phase 2 data backs investment

Sanofi reception

Sanofi’s Dupixent gains asthma approval in Europe

Drug on track to meet blockbuster forecasts

- PMLiVE

Bicycles Therapeutics enters dementia discovery with venture capital fund

Ambitious UK biotech expands research scope

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links